Zhu et al. found that cycloastragenol induced protective autophagy through the AMPK/ULK1/mTOR pathway and promoted apoptosis in human non-small cell lung cancer cell lines by upregulating NOXA expression (Zhu et al., 2024). Here, PRKAA2 is linked to non-small cell lung carcinoma.